Showing 1 - 10 of 225
The next generation of artificial vision devices (AVDs), which is currently developed in pre-clinical settings, has the … potential to improve the vision of blind patients with retinitis pigmentosa (RP) in a manner that they will be categorized as … visual impaired but no more as blind. This unprecedented vision improvement will result in a mentionable quality of life gain …
Persistent link: https://www.econbiz.de/10011599786
The next generation of artificial vision devices (AVDs), which is currently developed in pre-clinical settings, has the … potential to improve the vision of blind patients with retinitis pigmentosa (RP) in a manner that they will be categorized as … visual impaired but no more as blind. This unprecedented vision improvement will result in a mentionable quality of life gain …
Persistent link: https://www.econbiz.de/10010526936
Persistent link: https://www.econbiz.de/10012221642
Persistent link: https://www.econbiz.de/10014574593
upon some of Saramago's literary achievements. Findings – Black blindness, e.g. the absence of vision through an extreme …Purpose – Seeing, one might say, is everything between black blindness and white blindness: between not seeing because … that which produces vision (usually the sun or God). Within organizational literature, organizations have often been linked …
Persistent link: https://www.econbiz.de/10014891167
infant blindness prevention set up to serve rural India. Design/methodology/approach – The paper describes the two‐plus years … initiative paved the way for the first public‐private partnership in infant blindness prevention in India which is poised for a …
Persistent link: https://www.econbiz.de/10014874928
Purpose – The purpose of this study is to examine the health and social care information needs of people with a visual impairment; to identify the health and social care information sources used by visually‐impaired people seeking information; to identify differences in the information needs...
Persistent link: https://www.econbiz.de/10014671672
We consider a dose-finding trial in phase IIB of drug development. For choosing an appropriate design for this trial the specification of two points is critical: an appropriate model for describing the dose-effect relationship and the specification of the aims of the trial (objectives), which...
Persistent link: https://www.econbiz.de/10010298204
Introduction: Common approaches in cost-effectiveness analyses do not adjust for confounders. In nonrandomized studies this can result in biased results. Parametric models such as regression models are commonly applied to adjust for confounding, but there are several issues which need to be...
Persistent link: https://www.econbiz.de/10011599766
Abstract A common problem of interest within a randomized clinical trial is the evaluation of an inexpensive response endpoint as a valid surrogate endpoint for a clinical endpoint, where a chief purpose of a valid surrogate is to provide a way to make correct inferences on clinical treatment...
Persistent link: https://www.econbiz.de/10014610809